Lv1
30 积分 2024-04-07 加入
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
27天前
已完结
Myeloid beta-arrestin 2 depletion attenuates metabolic dysfunction-associated steatohepatitis via the metabolic reprogramming of macrophages
1个月前
已完结
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
1个月前
已完结
Triggering and resolution of inflammation in NASH
1个月前
已完结
Hepatic inflammatory responses in liver fibrosis
1个月前
已完结
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation
1个月前
已完结
Schwann cell transient receptor potential ankyrin 1 (TRPA1) ortholog in zebrafish larvae mediates chemotherapy‐induced peripheral neuropathy
1个月前
已完结
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
1个月前
已完结
Envisioning how to advance the MASH field
1个月前
已完结
Liver-specific actions of GH and IGF1 that protect against MASLD
1个月前
已完结
皖公网安备34019202002308
